• Explore /
  • Poster
  • / First-in-class microbial ecosystem therapeutics 4 (MET4) in metastatic solid cancer patients treated with immunotherapy: MET4-IO.

First-in-class microbial ecosystem therapeutics 4 (MET4) in metastatic solid cancer patients treated with immunotherapy: MET4-IO.

Abstract Poster

Authors

Daniel Araujo

Daniel Vilarim Araujo

Princess Margaret Cancer Centre, Toronto, ON, Canada

Daniel Vilarim Araujo , Marc Oliva Bernal , Tira Jing Ying Tan , Alya Abbas Heirali , Pierre H.H. Schneeberger , Thiago Pimentel Muniz , Bo Chen , Lee-Anne Stayner , Kathy Xia , Aaron Richard Hansen , Ben X Wang , David Hogg , Kyla Cochrane , Shawn Langer , Nissim Mashiach , Wei Xu , Lillian L. Siu , Bryan Coburn , Anna Spreafico

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

New Targets and New Technologies (IO)

Clinical Trial Registration Number

NCT03686202

Citation

J Clin Oncol 38: 2020 (suppl; abstr 3098)

DOI

10.1200/JCO.2020.38.15_suppl.3098

Abstract #

3098

Poster Bd #

162

Abstract Disclosures

Similar Posters

First Author: Tira Jing Ying Tan

First Author: Vivek Subbiah

First Author: Ana Carneiro

First Author: Colette Shen